Koehm M - Search Results

1

Omics and Multi-Omics Analysis for the Early Identification and Improved Outcome of Patients with Psoriatic Arthritis.

Gurke R, Bendes A, Bowes J, Koehm M, Twyman RM, Barton A, Elewaut D, Goodyear C, Hahnefeld L, Hillenbrand R, Hunter E, Ibberson M, Ioannidis V, Kugler S, Lories RJ, Resch E, Rüping S, Scholich K, Schwenk JM, Waddington JC, Whitfield P, Geisslinger G, FitzGerald O, Behrens F, Pennington SR; HIPPOCRATES Consortium. Gurke R, et al. Among authors: koehm m. Biomedicines. 2022 Sep 24;10(10):2387. doi: 10.3390/biomedicines10102387. Biomedicines. 2022. PMID: 36289648 Free PMC article. Review.

2

The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies.

Hunzelmann N, Riemekasten G, Becker MO, Moinzadeh P, Kreuter A, Melchers I, Mueller-Ladner U, Meier F, Worm M, Lee H, Herrgott I, Pfeiffer C, Fierlbeck G, Henes J, Juche A, Zeidler G, Mensing H, Günther C, Sárdy M, Burkhardt H, Koehm M, Kuhr K, Krieg T, Sunderkötter C. Hunzelmann N, et al. Among authors: koehm m. Br J Dermatol. 2016 Jun;174(6):1384-7. doi: 10.1111/bjd.14367. Epub 2016 Mar 20. Br J Dermatol. 2016. PMID: 26708835 No abstract available.

3

Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.

Behrens F, Koehm M, Burkhardt H. Behrens F, et al. Among authors: koehm m. Curr Opin Rheumatol. 2011 May;23(3):282-7. doi: 10.1097/BOR.0b013e328344fddb. Curr Opin Rheumatol. 2011. PMID: 21427581 Review.

4

Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study.

Behrens F, Koehm M, Arndt U, Wittig BM, Greger G, Thaçi D, Scharbatke E, Tony HP, Burkhardt H. Behrens F, et al. Among authors: koehm m. J Rheumatol. 2016 Mar;43(3):632-9. doi: 10.3899/jrheum.141596. Epub 2015 Dec 15. J Rheumatol. 2016. PMID: 26669916 Free article.

5

Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis.

Scharbatke EC, Behrens F, Schmalzing M, Koehm M, Greger G, Gnann H, Burkhardt H, Tony HP. Scharbatke EC, et al. Among authors: koehm m. Arthritis Care Res (Hoboken). 2016 Nov;68(11):1607-1615. doi: 10.1002/acr.22884. Epub 2016 Oct 1. Arthritis Care Res (Hoboken). 2016. PMID: 26990995 Free PMC article.

6

Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis.

Behrens F, Koehm M, Thaçi D, Gnann H, Greger G, Maria Wittig B, Burkhardt H. Behrens F, et al. Among authors: koehm m. Rheumatology (Oxford). 2016 Oct;55(10):1791-5. doi: 10.1093/rheumatology/kew229. Epub 2016 Jun 21. Rheumatology (Oxford). 2016. PMID: 27330166 Free PMC article.

7

Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab.

Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Gnann H, Greger G, Tony HP, Burkhardt H. Behrens F, et al. Among authors: koehm m. Rheumatology (Oxford). 2018 Nov 1;57(11):1938-1946. doi: 10.1093/rheumatology/key203. Rheumatology (Oxford). 2018. PMID: 30010891 Free PMC article.

8

Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis.

Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Wittig BM, Gnann H, Greger G, Tony HP, Burkhardt H. Behrens F, et al. Among authors: koehm m. Scand J Rheumatol. 2019 Sep;48(5):375-382. doi: 10.1080/03009742.2019.1600717. Epub 2019 Jul 16. Scand J Rheumatol. 2019. PMID: 31311386

9

Use of a "critical difference" statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis.

Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Gnann H, Greger G, Tony HP, Burkhardt H. Behrens F, et al. Among authors: koehm m. BMC Rheumatol. 2019 Dec 10;3:51. doi: 10.1186/s41927-019-0095-2. eCollection 2019. BMC Rheumatol. 2019. PMID: 31867564 Free PMC article.

10

Individual therapeutic DAS28-d_crit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies.

Koehm M, McIntosh MJ, Hofmann MW, Abraham V, Gabay C, Choy EH, Kavanaugh A, Burkhardt H, Behrens F. Koehm M, et al. Rheumatol Int. 2020 May;40(5):747-755. doi: 10.1007/s00296-020-04514-7. Epub 2020 Feb 10. Rheumatol Int. 2020. PMID: 32040761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page